The European Union this week posted regulations that upon the U.K.’s exit for the EU its API makers will be treated like those from China and India.
Particle Sciences will have commercial manufacturing capabilities operating at its Pennsylvania facility by the end of the year and will add 30 jobs.
Dr. Reddy’s is recalling 765,058 cartons of its Zenatane acne med, which was manufactured for it by compatriot Cipla.
Albany-New York based AMRI has agreed to a buyout worth more than $920 million as the M&A market for contract manufacturers continues to run hot.
CordenPharma has joined the small but growing cadre of pharma companies adding continuous manufacturing to their mix of manufacturing operations.
Lonza, which is dealing with FDA concerns about its cell manufacturing facility in the U.S., has acquired a gene and cell CMO in Europe.
Roche has recalled all of its 5-mg Valium blister packs in Australia after uncovering a supply chain breach at a distributor's warehouse.
Earlier this month, the FDA banned all products being shipped to the U.S. by a Chinese API maker, and a new warning letter explains why. It appears the…
The manufacturing problems at Sun Pharma’s key Halol, India, plant have again stymied approval of a new drug from Sun's novel drug development group,…
Hospitals are dealing with a shortage of sodium bicarbonate, a drug whose active ingredient is essentially the same one that cooks know as baking soda.…